Vericel to Present at 29th Annual Piper Jaffray Healthcare Conference

CAMBRIDGE, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation VCEL, a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the 29th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace in New York City, NY on Wednesday, November 29, 2017, at 2:00pm Eastern time.

The presentation will be webcast live at https://pgi.webcasts.com/viewer/event.jsp?ei=1172021&tp_key=ab3cbde8f8, and may be accessed from the news and events section of the Vericel website.

About Vericel Corporation

Vericel develops, manufactures, and markets expanded autologous cell therapies for the treatment of patients with serious diseases and conditions. The company markets two cell therapy products in the United States. Vericel is marketing MACI® (autologous cultured chondrocytes on porcine collagen membrane), an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Vericel is also marketing Epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. For more information, please visit the company's website at www.vcel.com.

Epicel® and MACI® are registered trademarks of Vericel Corporation. © 2017 Vericel Corporation. All rights reserved.

Global Media Contacts:

David Schull

Russo Partners LLC

+1 212-845-4271 (office)

+1 858-717-2310 (mobile)

David.schull@russopartnersllc.com

Karen Chase

Russo Partners LLC

+1 646-942-5627 (office)

+1 917-547-0434 (mobile)

Karen.chase@russopartnersllc.com

Investor Contacts:

Chad Rubin

The Trout Group

crubin@troutgroup.com

+1 (646) 378-2947

Lee Stern

The Trout Group

lstern@troutgroup.com

+1 (646) 378-2922

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!